Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2000-10-30
2008-09-09
Ewoldt, G. R. (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C536S001110
Reexamination Certificate
active
07422748
ABSTRACT:
A composition comprising an aqueous solution comprising:(i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence, and(ii) as an adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15.
REFERENCES:
patent: 3678149 (1972-07-01), Prigal
patent: 5424067 (1995-06-01), Brancq et al.
patent: 6103770 (2000-08-01), Trouve
patent: 6117432 (2000-09-01), Ganne et al.
patent: 6274149 (2001-08-01), Ganne
Perlaza et al. Infec & Immun 66(7):3423-3428, 1998.
O'Neill et al. J Pharm Sci. 61(6):863, 1972.
P. R. Garrett, Defoaming: Theory and Industrial Applications, Surfactant Science Series; vol. 45, 1993, p. 300, Marcel Dekker Inc., New York, New York.
Abstract for W. C. Griffin, “Calculation of HLB Values Of Non-Ionic Surfactants” Journal of the Society of Cosmetic Chemists 5 (1954):259.
The Thesaurus Of Chemical Products, vol. II: Tradename to Generic, 1986, pp. 64, 283-284, Chemical Publishing Co., New York, New York.
Abstract of FR 2733151 “Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence”, esp@cenet database-worldwide, Oct. 25, 1996 Ganne, V.
Abstract of FR 2754715, “Adjuvant, Notamment Sous Forme D'Une Emulsion Contenant Un Cation Metallique Trivalent Et Composition Vaccinale Le Comprenant (A1 B1) Adjuvant, Notamment Sous Forme D'Une Emulsion Contenant Un Cation Metallique Trivalent Et Composition Vaccinale Le Comprenant”, esp@cenet database-worldwide, Apr. 24, 1998 Ganne et al.
Abstract of FR 2729307, “Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds”, esp@cenet database-worldwide, Jul. 19, 1996 Trouve, G.
Abstract of FR 2754182, “Nouvelles Compositions Vaccinales Comportant Comme Adjuvant Un Compose Sympathomimetique (A1 B1) Nouvelles Compositions Vaccinales Comportant Comme Adjuvant Un Compose Sympathomimetique”, esp@cenet database-worldwide, Apr. 10, 1998 Bout et al.
Abstract of FR 2649012, “Injectable multi-phase emulsions”, esp@cenet database-worldwide, Jan. 4, 1991 Brancq et al.
U.S. Appl. No. 08/946,114, “New Vaccine Composition Comprising, As Adjuvant, A Sympathomimetic Compound.”
Aucouturier Jerome
Ganne Vincent
Trouve Gerard
Ewoldt G. R.
Hunton & Williams LLP
Societe d'Exploitation de Produits pour les Industries Chimiques
LandOfFree
Vaccine composition of surfactants as adjuvant of immunity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine composition of surfactants as adjuvant of immunity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition of surfactants as adjuvant of immunity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3977491